EMERGENCY COVID-19 TREATMENT APPROVED

FDA Okays Gilead's Remdesivir Drug

Source:  Gilead Sciences Remdesivir

Good News in COVID-19 Fight
Finally, some good news to report on the
war against COVID-19.  The US
Food and Drug Administration has
given emergency approval to Gilead
Sciences' remdesivir drug to treat 
patients with the coronavirus.  President
Donald Trump made the announcement.
Gilead CEO Daniel O'Day promised that
the company is going to donate one 
million vials of the drug for treating 
patients.

Results Tell the Story
The FDA emergency order means that
doctors can use the drug even though it
hasn't gone through the FDA's formal,
time-consuming approval process.  The
results on this unique drug tell the story.
An independent analysis by the US National 
Institute of Allergy & Infectious Diseases
showed that COVID patients who took
the drug usually recovered after 11 days.
That is 4 days earlier than patients not given
the drug.  

More Compelling Results
Gilead's own study shows at least 50%
of severe COVID-19 patients treated 
with a 5-day dosage improved.   The number
of severe COVID patients treated was 397.

Production Ramp-Up
Gilead expects to produce one
million rounds of the drug by the
end of 2020.  They will produce
several million rounds next year.  3.2
million people have the virus
right now.  This is great news
that a treatment is now ready 
to enter the COVID-19 battle.

To browse my recent books on breakthrough
innovations like this,
go to 
amazon.com/author/ekane



... ...